Home » Healthcare » Hydatid Disease Treatment Market

Hydatid Disease Treatment Market By Treatment Type (Medical Treatment, Antiparasitic Medications (e.g., Albendazole, Mebendazole), Surgical Treatment, Cyst Removal (Cystectomy), Cyst Aspiration and Injection of Protoscolicidal Agent (PAIR), Partial Liver Resection, Other Surgical Procedures), By Site of Infection (Hepatic Hydatid Disease (Infection in the Liver), Pulmonary Hydatid Disease (Infection in the Lungs), Other Organs (e.g., Brain, Kidneys) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2028

Price: $4999

Published: | Report ID: 22012 | Report Format : PDF

Market Insights

  • The global demand for hydatid disease treatment was valued at USD XX Million in 2022 and is expected to reach USD XX Million in 2030, growing at a CAGR of 5.6% between 2023 and 2030.
  • The medical treatment segment is the market leader by treatment type, accounting for more than 58% of total value in 2022, while the surgical treatment segment is estimated to grow rapidly over the projection period.
  • The hospitals and clinics end-user category is expected to expand rapidly in the forecast period, while the surgical centers segment has the highest market share in 2022.
  • The complicated cysts severity dominates the global need for hydatid disease treatment, accounting for more than 55% in 2022 and is predicted to expand at a high CAGR.
  • The hepatic hydatid disease category dominated the market with 40% of the total revenue share by site of infection. In contrast, the pulmonary hydatid disease category will expand fastest over the projected time frame.
  • North America is driving the rapid expansion of the hydatid disease treatment industry, accounting for more than one-third of the market in 2022, while Asia Pacific and Europe account for just under 54% of the market in 2022. In 2022, Europe had a market revenue share of more than 20%.
  • Hydatid disease, caused by the Echinococcus parasite, remains a major global health concern, particularly in regions where livestock farming is prevalent.
  • The global hydatid disease treatment market primarily relies on surgical interventions and pharmacological therapy for managing the condition.
  • The zoonotic nature of hydatid disease highlights the importance of controlling the infection in humans and animals to prevent transmission.
  • Surgical removal of cysts is the most common hydatid disease treatment approach. Techniques like cystectomy, pericystectomy, and hepatic resection are frequently employed.

Executive Summary

Market Definition

The hydatid disease treatment market encompasses the healthcare sector that addresses the diagnosis, management, and prevention of hydatid disease, also known as echinococcosis. It includes a range of medical interventions, such as surgical procedures, pharmaceuticals, diagnostic tools, and associated healthcare services, to combat this zoonotic parasitic infection in humans and animals. This market involves key stakeholders, including healthcare providers, pharmaceutical companies, medical device manufacturers, research organizations, and government agencies, all working to enhance treatment outcomes and reduce the prevalence of hydatid disease.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Overview

The global hydatid disease treatment market has witnessed rapid growth in recent years and is expected to grow at a CAGR of 5.6% between 2023 and 2030. The market was valued at USD XX million in 2022 and is expected to reach USD XX million in 2030.

Echinococcosis, sometimes referred to as hydatid sickness, is a contagious illness brought on by the larvae of the tapeworms Echinococcus granulosus or Echinococcus multilocularis. Although it can affect other organs including the brain and spleen, it primarily affects the liver and lungs. Hydatid illness is normally treated with a combination of surgery and medication. The primary drug treatment for hydatid illness is the use of anthelmintic medicines. Albendazole and mebendazole are the most commonly used medications for treating hydatid illness. These benzimidazole medicines effectively treat the larval phases of Echinococcus granulosus and Echinococcus multilocularis, parasitic organisms that cause hydatid illness.

Hydatid disease is a major public health hazard in many parts of the world, particularly in rural areas where animal raising is prominent. The high frequency and incidence of the disease generate a need for efficient treatment alternatives, driving up the market for treating hydatid disease globally. Human incidence rates for cystic echinococcosis, for example, can surpass 50 per 100,000 person-years in endemic places, with occurrence levels as high as 5%-10% in Argentina, Peru, East Africa, Central Asia, and China, according to a WHO factsheet published in May 2021. Increased awareness of hydatid illness and improved diagnostic procedures aid in early detection and treatment. As diagnostic abilities increase, more instances are diagnosed, raising the demand for treatment choices.

Segmentation by Treatment Type

  • The surgical treatment segment will exhibit the highest CAGR in the forecasted period. Surgical interventions like cystectomy, pericystectomy, and hepatic resection are crucial for managing hydatid disease.
  • The medical treatment segment currently leads the market share, holding over 58% in 2022. Anthelmintic drugs such as albendazole and mebendazole play a major role in preventing recurrence and managing residual cysts.

Segmentation by Site of Infection

  • The pulmonary hydatid disease (infection in the lungs) segment is expected to achieve the highest CAGR over the projected period. It often requires specialized treatment approaches.
  • The hepatic hydatid disease (infection in the liver) segment is leading the market share with over 40% share in 2022. The liver is a common site for hydatid cysts, necessitating diverse treatment modalities.

Segmentation by End-User

  • Hospitals and clinics are the dominant category, satisfying more than 44% of global demand for hydatid disease treatment in 2022, with strong growth expectations. They serve as primary healthcare facilities for diagnosis and treatment.
  • Surgical centers offer alternative treatment methods, including minimally invasive procedures, ensuring comprehensive coverage to address varying therapeutic needs.

Segmentation by Severity and Stage of Disease

  • The uncomplicated cysts segment is anticipated to witness the highest CAGR in the coming years, as early intervention and pharmacological treatment can effectively manage these cases.
  • Complicated cysts (ruptured, infected, or occupying critical locations) currently lead the global market share, holding over 55% in 2022. These cases often require complex surgical procedures and intensive care.

Segmentation by Region

  • North America remains notably profitable for industry players, accounting for over one-third of the share in 2022, driven by advanced healthcare infrastructure and research.
  • Europe and Asia Pacific contributed just under 54% share in 2022. With over 20% share, Europe demonstrates a robust market presence due to its developed healthcare systems and research activities.
  • The rest of the world, including Latin America, the Middle East, and Africa, fulfills the remaining demand for hydatid disease treatment, highlighting the global distribution of the disease and the need for diverse treatment approaches.

Organisms like bacteria, fungi, viruses, or parasites cause infectious illnesses. These illnesses can be transmitted by insects, animals, consuming contaminated food or drink, or exposure to an infected environment. The rising frequency of infectious diseases and increased awareness of these disorders will likely fuel the growth of the hydatid disease treatment industry. According to a WHO article, approximately 50,000 people die daily from infectious diseases.

In 2022, North America held the majority of the revenue share of the global hydatid disease treatment market. North America benefits from well-established healthcare infrastructure and access to advanced medical technologies, facilitating early diagnosis and effective treatment. Furthermore, heightened regional awareness of hydatid disease and zoonotic infections has led to early detection and management of cases. Moreover, rigorous R&D efforts in North America have resulted in the development innovative treatment modalities and pharmaceuticals, further driving market growth. Moreover, government initiatives, public health campaigns, and collaborations with international organizations have helped enhance disease control and treatment efforts, making North America a dominant region in the global hydatid disease treatment market.

Over the projection period, Asia Pacific is expected to be the fastest-growing region. Asia Pacific includes regions with a high prevalence of hydatid disease, particularly in rural areas where livestock farming is common. As healthcare infrastructure improves and awareness campaigns gain traction, more cases will likely be diagnosed and treated. The growing regional population, especially in countries like India and China, presents a substantial patient pool, propelling the demand for hydatid disease treatment. Additionally, rising economic development in Asia Pacific will likely increase healthcare expenditure, facilitating access to advanced treatment modalities. Moreover, ongoing R&D efforts and collaborations between regional and international healthcare organizations are expected to introduce innovative therapies and enhance disease management practices, contributing to the rapid regional market growth.

The availability of effective hydatid disease treatments, such as albendazole, is critical in managing the infection. Ongoing R&D efforts to identify new treatments or improve existing ones assist in propelling the treatment market forward.

Collaborations between countries, international organizations, and research institutes also allow for exchanging knowledge and resources, improving hydatid disease treatment options. These collaborations increase diagnostics, surgery, and medicine, further boosting the hydatid disease treatment market share.

Key Highlights of the Report

The global hydatid disease treatment market is segmented by treatment type, site of infection, severity and stage of disease, end-user, and region. Surgical treatment types continue to drive growth with advanced surgical techniques and pharmaceutical therapies. Hospitals and clinics remain vital for diagnosis and treatment, and telemedicine solutions gain traction for remote patient management. Complicated cysts, including ruptured and infected cases, hold a significant market share.

The global hydatid disease treatment market growth is primarily driven by the persistent high prevalence of the disease in endemic regions, continuous advancements in treatment modalities, increasing awareness, and government support for disease control programs, all stimulating demand for treatments and promoting innovation. However, significant restraints include limited access to healthcare in rural areas, potential drug resistance, the risk of cyst recurrence post-treatment, economic barriers to treatment access, and the challenge of controlling the disease in animals. These constraints pose challenges to effective treatment and underline the importance of addressing various facets of the disease for comprehensive control and management.

North America leads the global market with advanced healthcare infrastructure, while Asia Pacific emerges as the fastest-growing region due to its high disease burden and expanding healthcare access. Collaboration between the healthcare and agriculture sectors becomes crucial for zoonotic control.

What Are The Main Drivers Of The Global Hydatid Disease Treatment Market?

The main drivers of the global hydatid disease treatment market include the persistently high prevalence of hydatid disease in endemic regions, growing awareness of the disease, improved diagnostic capabilities, advancements in surgical techniques, and ongoing R&D efforts to enhance treatment modalities. Moreover, increased government and international support for hydatid disease control programs and expanding healthcare infrastructure in emerging economies contribute to market growth. The rising demand for anthelmintic drugs and the potential for innovative therapies are also key factors propelling the market forward, as they address the need for effective, accessible, and comprehensive treatment options for this parasitic infection.

What Are The Major Challenges Faced By The Global Hydatid Disease Treatment Market?

The major challenges faced by the global hydatid disease treatment market encompass limited access to healthcare in remote and rural areas, particularly in high-endemic regions where healthcare infrastructure is underdeveloped. Drug resistance and the potential for cyst recurrence post-treatment pose clinical challenges. At the same time, the zoonotic nature of the disease necessitates a coordinated effort to control it in both humans and animals. Besides, the cost of treatment and surgical expertise required for complex cases can be prohibitive for some patients. Addressing these challenges requires a multifaceted approach combining improved healthcare access, research into drug-resistant strains, and awareness campaigns to reduce transmission and ensure timely diagnosis and treatment.

What Are The Growth Opportunities In The Global Hydatid Disease Treatment Market?

The global hydatid disease treatment market presents several growth opportunities, including increasing awareness about the disease and its prevention, expanding access to healthcare in underserved regions, and ongoing research into innovative treatment modalities. Collaborative efforts between governments, healthcare organizations, and NGOs can lead to the development of comprehensive disease control programs, opening doors for market expansion. Moreover, advancements in diagnostic technologies, such as portable ultrasound devices, telemedicine solutions, and point-of-care testing, offer potential growth avenues for early detection and monitoring. Investment in research and development for novel therapies and drug combinations can further enhance treatment outcomes and drive market growth.

Market Drivers

Several factors drive the global hydatid disease treatment market. The following are the key drivers of the global hydatid disease treatment market:

Higher Disease Prevalence in Endemic Regions

One of the primary drivers of the hydatid disease treatment market is the persistently high disease prevalence in endemic regions. Hydatid disease is prevalent in areas where livestock farming is common, such as parts of South America, the Mediterranean, Central Asia, and some parts of Africa. In these regions, people are at a higher risk of contracting the disease due to close contact with infected animals. The large number of cases in these areas drives the demand for hydatid disease treatment, including surgical interventions and pharmaceuticals. As awareness about the disease spreads and diagnostic capabilities improve, more cases are diagnosed and treated, further contributing to the growth of the treatment market.

Market Restraints

The global hydatid disease treatment market faces challenges that may hinder its growth. These include the following:

Limited Access to Healthcare in Rural Areas

A key restraint in the hydatid disease treatment market is the limited access to healthcare facilities, particularly in rural and underserved areas of endemic regions. Hydatid disease is most prevalent in remote agricultural communities, where healthcare infrastructure and specialized medical expertise are often lacking. Patients in these areas may face challenges in accessing timely and appropriate treatment, leading to delayed diagnosis and more advanced disease stages upon presentation to healthcare facilities. This limitation hampers the effectiveness of treatment programs and poses a barrier to reducing disease burden, as early intervention is crucial for favorable outcomes.

Opportunities

The global hydatid disease treatment market offers significant growth opportunities. These include the following:

Emerging Research into Novel Therapies

Ongoing research into novel therapies presents a promising opportunity for the hydatid disease treatment market. Scientists are exploring innovative approaches, such as immunomodulators, targeted drug delivery systems, and combination therapies, to improve the efficacy and safety of hydatid disease treatment. Immunomodulators can enhance the body’s immune response against the parasite, while targeted drug delivery systems can improve drug effectiveness and minimize side effects. Moreover, combination therapies involving multiple drugs with complementary mechanisms of action may reduce the risk of drug resistance and enhance treatment outcomes. Investing in the development and clinical testing of these novel therapies can open new avenues for more effective and sustainable hydatid disease treatment options in the future.

Competitive Landscape

Key Players

The competitive landscape in the global hydatid disease treatment market is marked by a mix of pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions actively addressing the disease. Some of the major players in the market and their market share are as follows:

  • Amneal Pharmaceuticals LLC
  • GSK Plc
  • Abbott Laboratories Inc
  • Merck KGaA
  • Janssen Global Services LLC (Johnson & Johnson Services Inc)
  • Lupin Limited
  • Cadila Pharmaceuticals Limited
  • Zydus Group
  • Mankind Pharma
  • Ipca Laboratories Ltd
  • Others

These entities compete in developing advanced pharmaceuticals, surgical techniques, and diagnostic tools to improve treatment outcomes. Collaboration and partnerships among industry players, governments, and non-profit organizations are common strategies to pool resources for research, awareness campaigns, and access expansion. Market competition is influenced by treatment efficacy, cost-effectiveness, and the ability to provide comprehensive solutions for hydatid disease, including surgical and pharmaceutical interventions. Regulatory approvals and adherence to international health guidelines play a significant role in shaping the competitive dynamics of this specialized healthcare segment.

In October 2022, Seres Therapeutics Inc, the leading microbiome therapeutics company, announced that the US FDA has accepted for priority review its Biologics Licence Application for Investigational Microbiome Treatment SER-109 for Recurrent C. Difficile Infections.

In March 2022, May & Baker Nigeria PLC introduced Artelum Combo, a novel medicine to combat malaria parasites nationwide. The medication is a one-of-a-kind combination of Artemether Lumefantrine and Paracetamol that delivers comprehensive malaria treatment in a single dose.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The global hydatid disease treatment market is witnessing steady growth due to increased awareness, improved diagnostic methods, and advancements in surgical techniques.
  • Market segmented by treatment type, site of infection, severity and stage of disease, end-user, and region.
  • Anthelmintic drugs, such as albendazole and mebendazole, are administered to complement surgery or for patients who cannot undergo surgery. These drugs help in preventing recurrence and managing residual cysts.
  • The prevalence and treatment practices for hydatid disease vary by region. High-endemic areas include parts of South America, the Mediterranean, Central Asia, and some parts of Africa.
  • Advancements in imaging technologies like ultrasound, CT scans, and MRI have enhanced the diagnosis and monitoring of hydatid cysts, boosting the demand for treatment.
  • Challenges in the hydatid disease treatment market include limited access to healthcare in rural areas, drug resistance, and the potential for cyst recurrence after treatment.

Future Outlook

  • Emerging markets, particularly in Asia-Pacific and Latin America, present robust growth opportunities as healthcare infrastructure improves, increasing awareness and diagnosis rates of hydatid disease.
  • Research into novel drug combinations, immunomodulators, and targeted delivery systems may offer more effective and safer pharmacological treatments.
  • International partnerships and government initiatives are expected to continue, supporting disease control programs, awareness campaigns, and research efforts.

Segmentation

  • By Treatment Type
    • Medical Treatment
      • Antiparasitic Medications (e.g., Albendazole, Mebendazole)
    • Surgical Treatment
      • Cyst Removal (Cystectomy)
      • Cyst Aspiration and Injection of Protoscolicidal Agent (PAIR)
      • Partial Liver Resection
      • Other Surgical Procedures
    • By Site of Infection
      • Hepatic Hydatid Disease (Infection in the Liver)
      • Pulmonary Hydatid Disease (Infection in the Lungs)
      • Other Organs (e.g., Brain, Kidneys)
    • By End-User
      • Hospitals and Clinics
      • Surgical Centers
      • Research and Academic Institutions
    • By Severity and Stage of Disease
      • Uncomplicated Cysts
      • Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations)
    • By Region
      • North America
        • U.S.
        • Canada
        • Mexico
      • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
        • Rest of Europe
      • Asia Pacific
        • China
        • Japan
        • India
        • South Korea
        • South-east Asia
        • Rest of Asia Pacific
      • Latin America
        • Brazil
        • Argentina
        • Rest of Latin America
      • Middle East & Africa
        • GCC Countries
        • South Africa
        • Rest of the Middle East and Africa

Adjacent Markets

Several adjacent markets have high revenue growth opportunities in the hydatid disease treatment market. The key adjacent markets for hydatid disease treatment market –

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Hydatid Disease Treatment Market

2.1.1. Global Hydatid Disease Treatment Market, By Treatment Type

2.1.2. Global Hydatid Disease Treatment Market, By Site of Infection

2.1.3. Global Hydatid Disease Treatment Market, By End-User

2.1.4. Global Hydatid Disease Treatment Market, By Severity and Stage of Disease

2.1.5. Global Hydatid Disease Treatment Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Hydatid Disease Treatment Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Hydatid Disease Treatment Market Drivers

3.2.2. Hydatid Disease Treatment Market Restraints

3.2.3. Hydatid Disease Treatment Market Opportunities

3.2.4. Major Hydatid Disease Treatment Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Treatment Type

3.5.2. Site of Infection

3.5.3. End-User

3.5.4. Severity and Stage of Disease

3.5.5. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Hydatid Disease Treatment Market: Company Market Share, Value 2022

4.1.2. Global Hydatid Disease Treatment Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Hydatid Disease Treatment Market: Top 3 Company Market Share, Value 2022

4.2. Global Hydatid Disease Treatment Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Hydatid Disease Treatment Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID-19 and Russia – Ukraine War on Hydatid Disease Treatment Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Hydatid Disease Treatment Market, By Treatment Type

8.1. Global Hydatid Disease Treatment Market Overview, by Treatment Type

8.1.1. Global Hydatid Disease Treatment Market Revenue Share, By Treatment Type, 2022 Vs 2030 (in %)

8.2. Medical Treatment

8.2.1. Global Hydatid Disease Treatment Market, By Medical Treatment, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for Medical Treatment

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Surgical Treatment

8.3.1. Global Hydatid Disease Treatment Market, By Surgical Treatment, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for Surgical Treatment

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

 

9. Global Hydatid Disease Treatment Market, By Site of Infection

9.1. Global Hydatid Disease Treatment Market Overview, by Site of Infection

9.1.1. Global Hydatid Disease Treatment Market Revenue Share, By Site of Infection, 2022 Vs 2030 (in %)

9.2. Hepatic Hydatid Disease (Infection in the Liver)

9.2.1. Global Hydatid Disease Treatment Market, By Hepatic Hydatid Disease (Infection in the Liver), By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Hepatic Hydatid Disease (Infection in the Liver)

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Pulmonary Hydatid Disease (Infection in the Lungs)

9.3.1. Global Hydatid Disease Treatment Market, By Pulmonary Hydatid Disease (Infection in the Lungs), By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Pulmonary Hydatid Disease (Infection in the Lungs)

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Other Organs (e.g., Brain, Kidneys)

9.4.1. Global Hydatid Disease Treatment Market, By Other Organs (e.g., Brain, Kidneys), By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Other Organs (e.g., Brain, Kidneys)

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

 

10. Global Hydatid Disease Treatment Market, By End-User

10.1. Global Hydatid Disease Treatment Market Overview, by End-User

10.1.1. Global Hydatid Disease Treatment Market Revenue Share, By End-User, 2022 Vs 2030 (in %)

10.2. Hospitals and Clinics

10.2.1. Global Hydatid Disease Treatment Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Hospitals and Clinics

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Surgical Centers

10.3.1. Global Hydatid Disease Treatment Market, By Surgical Centers, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Surgical Centers

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

10.4. Research and Academic Institutions

10.4.1. Global Hydatid Disease Treatment Market, By Research and Academic Institutions, By Region, 2017-2030 (US$ Mn)

10.4.2. Market Dynamics for Research and Academic Institutions

10.4.2.1. Drivers

10.4.2.2. Restraints

10.4.2.3. Opportunities

10.4.2.4. Trends

 

11. Global Hydatid Disease Treatment Market, By Severity and Stage of Disease

11.1. Global Hydatid Disease Treatment Market Overview, by Severity and Stage of Disease

11.1.1. Global Hydatid Disease Treatment Market Revenue Share, By Severity and Stage of Disease, 2022 Vs 2030 (in %)

11.2. Uncomplicated Cysts

11.2.1. Global Hydatid Disease Treatment Market, By Uncomplicated Cysts, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Uncomplicated Cysts

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations)

11.3.1. Global Hydatid Disease Treatment Market, By Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations), By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations)

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

 

12. Global Hydatid Disease Treatment Market, By Region

12.1. Global Hydatid Disease Treatment Market Overview, by Region

12.1.1. Global Hydatid Disease Treatment Market, By Region, 2022 vs 2030 (in%)

12.2. Treatment Type

12.2.1. Global Hydatid Disease Treatment Market, By Treatment Type, 2017-2030 (US$ Mn)

12.3. Site of Infection

12.3.1. Global Hydatid Disease Treatment Market, By Site of Infection, 2017-2030 (US$ Mn)

12.4. End-User

12.4.1. Global Hydatid Disease Treatment Market, By End-User, 2017-2030 (US$ Mn)

12.5. Severity and Stage of Disease

12.5.1. Global Hydatid Disease Treatment Market, By Severity and Stage of Disease, 2017-2030 (US$ Mn)

 

13. North America Hydatid Disease Treatment Market Analysis

13.1. Overview

13.1.1. Market Dynamics for North America

13.1.1.1. Drivers

13.1.1.2. Restraints

13.1.1.3. Opportunities

13.1.1.4. Trends

13.2. North America Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

13.2.1. Overview

13.2.2. SRC Analysis

13.3. North America Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

13.3.1. Overview

13.3.2. SRC Analysis

13.4. North America Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

13.4.1. Overview

13.4.2. SRC Analysis

13.5. North America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

13.5.1. Overview

13.5.2. SRC Analysis

13.6. North America Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

13.6.1. North America Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

13.6.2. U.S.

13.6.3. Canada

13.6.4. Mexico

 

14. Europe Hydatid Disease Treatment Market Analysis

14.1. Overview

14.1.1. Market Dynamics for North America

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. Europe Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. Europe Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. Europe Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. Europe Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

14.5.1. Overview

14.5.2. SRC Analysis

14.6. Europe Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

14.6.1. Europe Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

14.6.2. UK

14.6.3. France

14.6.4. Germany

14.6.5. Italy

14.6.6. Spain

14.6.7. Benelux

14.6.8. Russia

14.6.9. Rest of Europe

 

15. Asia Pacific Hydatid Disease Treatment Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. Asia Pacific Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. Asia Pacific Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. Asia Pacific Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. Asia Pacific Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. Asia Pacific Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

15.6.1. Asia Pacific Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

15.6.2. China

15.6.3. Japan

15.6.4. India

15.6.5. South Korea

15.6.6. South East Asia

15.6.7. Rest of Asia Pacific

 

16. Latin America Hydatid Disease Treatment Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Latin America Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Latin America Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Latin America Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Latin America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Latin America Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

16.6.1. Latin America Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

16.6.2. Brazil

16.6.3. Argentina

16.6.4. Rest of Latin America

 

17. Middle East Hydatid Disease Treatment Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Middle East Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Middle East Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Middle East Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Middle East Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Middle East Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

17.6.1. Middle East Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

17.6.2. UAE

17.6.3. Saudi Arabia

17.6.4. Rest of Middle East

 

18. Africa Hydatid Disease Treatment Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Africa Hydatid Disease Treatment Market, by Treatment Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Africa Hydatid Disease Treatment Market, by Site of Infection, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Africa Hydatid Disease Treatment Market, by End-User, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Africa Hydatid Disease Treatment Market, by Country, 2017-2030 (US$ Mn)

18.6.1. Middle East Hydatid Disease Treatment Market, by Country, 2022 Vs 2030 (in%)

18.6.2. South Africa

18.6.3. Egypt

18.6.4. Rest of Africa

 

19. Company Profiles

19.1. Amneal Pharmaceuticals LLC

19.1.1. Company Overview

19.1.2. Products/Services Portfolio

19.1.3. Geographical Presence

19.1.4. SWOT Analysis

19.1.5. Financial Summary

19.1.5.1. Market Revenue and Net Profit (2019-2022)

19.1.5.2. Business Segment Revenue Analysis

19.1.5.3. Geographical Revenue Analysis

19.2. GSK Plc

19.3. Abbott Laboratories Inc

19.4. Merck KGaA

19.5. Janssen Global Services LLC (Johnson & Johnson Services Inc)

19.6. Lupin Limited

19.7. Cadila Pharmaceuticals Limited

19.8. Zydus Group

19.9. Mankind Pharma

19.10. Ipca Laboratories Ltd

19.11. Others

 

20. Research Methodology

20.1. Research Methodology

20.2. Phase I – Secondary Research

20.3. Phase II – Data Modelling

20.3.1. Company Share Analysis Model

20.3.2. Revenue Based Modelling

20.4. Phase III – Primary Research

20.5. Research Limitations

20.5.1. Assumptions

 

List of Figures

FIG. 1 Global Hydatid Disease Treatment Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach

FIG. 3 Global Hydatid Disease Treatment Market Segmentation

FIG. 4 Global Hydatid Disease Treatment Market, by Treatment Type, 2022 (US$ Mn)

FIG. 5 Global Hydatid Disease Treatment Market, by Site of Infection, 2022 (US$ Mn)

FIG. 6 Global Hydatid Disease Treatment Market, by End-User, 2022 (US$ Mn)

FIG. 7 Global Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2022 (US$ Mn)

FIG. 8 Global Hydatid Disease Treatment Market, by Geography, 2022 (US$ Mn)

FIG. 9 Attractive Investment Proposition, by Treatment Type, 2022

FIG. 10 Attractive Investment Proposition, by Site of Infection, 2022

FIG. 11 Attractive Investment Proposition, by End-User, 2022

FIG. 12 Attractive Investment Proposition, by Severity and Stage of Disease, 2022

FIG. 13 Attractive Investment Proposition, by Geography, 2022

FIG. 14 Global Market Share Analysis of Key Hydatid Disease Treatment Market Manufacturers, 2022

FIG. 15 Global Market Positioning of Key Hydatid Disease Treatment Market Manufacturers, 2022

FIG. 16 Global Hydatid Disease Treatment Market Value Contribution, By Treatment Type, 2022 & 2030 (Value %)

FIG. 17 Global Hydatid Disease Treatment Market, by Medical Treatment, Value, 2017-2030 (US$ Mn)

FIG. 18 Global Hydatid Disease Treatment Market, by Surgical Treatment, Value, 2017-2030 (US$ Mn)

FIG. 19 Global Hydatid Disease Treatment Market Value Contribution, By Site of Infection, 2022 & 2030 (Value %)

FIG. 20 Global Hydatid Disease Treatment Market, by Hepatic Hydatid Disease (Infection in the Liver), Value, 2017-2030 (US$ Mn)

FIG. 21 Global Hydatid Disease Treatment Market, by Pulmonary Hydatid Disease (Infection in the Lungs), Value, 2017-2030 (US$ Mn)

FIG. 22 Global Hydatid Disease Treatment Market, by Other Organs (e.g., Brain, Kidneys), Value, 2017-2030 (US$ Mn)

FIG. 23 Global Hydatid Disease Treatment Market Value Contribution, By End-User, 2022 & 2030 (Value %)

FIG. 24 Global Hydatid Disease Treatment Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Hydatid Disease Treatment Market, by Surgical Centers, Value, 2017-2030 (US$ Mn)

FIG. 26 Global Hydatid Disease Treatment Market, by Research and Academic Institutions, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Hydatid Disease Treatment Market Value Contribution, By Severity and Stage of Disease, 2022 & 2030 (Value %)

FIG. 28 Global Hydatid Disease Treatment Market, by Uncomplicated Cysts, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Hydatid Disease Treatment Market, by Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations), Value, 2017-2030 (US$ Mn)

FIG. 30 North America Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 31 U.S. Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 32 Canada Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 33 Mexico Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 34 Europe Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 35 Germany Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 36 France Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 37 U.K. Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 38 Italy Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 39 Spain Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 40 Benelux Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 41 Russia Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 42 Rest of Europe Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 43 Asia Pacific Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 44 China Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 45 Japan Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 46 India Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 47 South Korea Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 48 South-East Asia Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 49 Rest of Asia Pacific Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 50 Latin America Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 51 Brazil Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 52 Argentina Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 53 Rest of Latin America Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 54 Middle East Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 55 UAE Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 56 Saudi Arabia Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 57 Rest of Middle East Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 58 Africa Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 59 South Africa Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 60 Egypt Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

FIG. 61 Rest of Africa Hydatid Disease Treatment Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global Hydatid Disease Treatment Market

TABLE 2 Global Hydatid Disease Treatment Market: Market Drivers Impact Analysis

TABLE 3 Global Hydatid Disease Treatment Market: Market Restraints Impact Analysis

TABLE 4 Global Hydatid Disease Treatment Market, by Competitive Benchmarking, 2022

TABLE 5 Global Hydatid Disease Treatment Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Hydatid Disease Treatment Market, by Key Strategies Analysis, 2022

TABLE 7 Global Hydatid Disease Treatment Market, by Medical Treatment, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Hydatid Disease Treatment Market, by Medical Treatment, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Hydatid Disease Treatment Market, by Surgical Treatment, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Hydatid Disease Treatment Market, by Surgical Treatment, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Hydatid Disease Treatment Market, by Hepatic Hydatid Disease (Infection in the Liver), By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Hydatid Disease Treatment Market, by Hepatic Hydatid Disease (Infection in the Liver), By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Hydatid Disease Treatment Market, by Pulmonary Hydatid Disease (Infection in the Lungs), By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Hydatid Disease Treatment Market, by Pulmonary Hydatid Disease (Infection in the Lungs), By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Hydatid Disease Treatment Market, by Other Organs (e.g., Brain, Kidneys), By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Hydatid Disease Treatment Market, by Other Organs (e.g., Brain, Kidneys), By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Hydatid Disease Treatment Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Hydatid Disease Treatment Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Hydatid Disease Treatment Market, by Surgical Centers, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Hydatid Disease Treatment Market, by Surgical Centers, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Hydatid Disease Treatment Market, by Research and Academic Institutions, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Hydatid Disease Treatment Market, by Research and Academic Institutions, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Hydatid Disease Treatment Market, by Uncomplicated Cysts, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Hydatid Disease Treatment Market, by Uncomplicated Cysts, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Hydatid Disease Treatment Market, by Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations), By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Hydatid Disease Treatment Market, by Complicated Cysts (Ruptured, Infected, or Occupying Critical Locations), By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 28 Global Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 29 Global Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 30 Global Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 31 Global Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 32 Global Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 33 Global Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 34 Global Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 35 Global Hydatid Disease Treatment Market, by Region, 2017-2022 (US$ Mn)

TABLE 36 Global Hydatid Disease Treatment Market, by Region, 2023-2030 (US$ Mn)

TABLE 37 North America Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 38 North America Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 39 North America Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 40 North America Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 41 North America Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 42 North America Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 43 North America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 44 North America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 45 North America Hydatid Disease Treatment Market, by Country, 2017-2022 (US$ Mn)

TABLE 46 North America Hydatid Disease Treatment Market, by Country, 2023-2030 (US$ Mn)

TABLE 47 United States Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 48 United States Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 49 United States Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 50 United States Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 51 United States Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 52 United States Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 53 United States Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 54 United States Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 55 Canada Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 56 Canada Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 57 Canada Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 58 Canada Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 59 Canada Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 60 Canada Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 61 Canada Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 62 Canada Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 63 Mexico Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 64 Mexico Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 65 Mexico Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 66 Mexico Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 67 Mexico Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 68 Mexico Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 69 Mexico Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 70 Mexico Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 71 Europe Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 72 Europe Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 73 Europe Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 74 Europe Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 75 Europe Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 76 Europe Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 77 Europe Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 78 Europe Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 79 Europe Hydatid Disease Treatment Market, by Country, 2017-2022 (US$ Mn)

TABLE 80 Europe Hydatid Disease Treatment Market, by Country, 2023-2030 (US$ Mn)

TABLE 81 Germany Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 82 Germany Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 83 Germany Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 84 Germany Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 85 Germany Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 86 Germany Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 87 Germany Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 88 Germany Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 89 France Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 90 France Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 91 France Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 92 France Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 93 France Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 94 France Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 95 France Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 96 France Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 97 United Kingdom Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 98 United Kingdom Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 99 United Kingdom Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 100 United Kingdom Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 101 United Kingdom Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 102 United Kingdom Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 103 United Kingdom Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 104 United Kingdom Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 105 Italy Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 106 Italy Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 107 Italy Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 108 Italy Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 109 Italy Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 110 Italy Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 111 Italy Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 112 Italy Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 113 Spain Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 114 Spain Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 115 Spain Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 116 Spain Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 117 Spain Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 118 Spain Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 119 Spain Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 120 Spain Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 121 Benelux Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 122 Benelux Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 123 Benelux Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 124 Benelux Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 125 Benelux Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 126 Benelux Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 127 Benelux Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 128 Benelux Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 129 Russia Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 130 Russia Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 131 Russia Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 132 Russia Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 133 Russia Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 134 Russia Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 135 Russia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 136 Russia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 137 Rest of Europe Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 138 Rest of Europe Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 139 Rest of Europe Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 140 Rest of Europe Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 141 Rest of Europe Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 142 Rest of Europe Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 143 Rest of Europe Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 144 Rest of Europe Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 145 Asia Pacific Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 146 Asia Pacific Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 147 Asia Pacific Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 148 Asia Pacific Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 149 Asia Pacific Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 150 Asia Pacific Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 151 Asia Pacific Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 152 Asia Pacific Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 153 China Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 154 China Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 155 China Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 156 China Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 157 China Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 158 China Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 159 China Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 160 China Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 161 Japan Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 162 Japan Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 163 Japan Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 164 Japan Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 165 Japan Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 166 Japan Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 167 Japan Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 168 Japan Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 169 India Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 170 India Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 171 India Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 172 India Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 173 India Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 174 India Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 175 India Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 176 India Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 177 South Korea Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 178 South Korea Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 179 South Korea Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 180 South Korea Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 181 South Korea Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 182 South Korea Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 183 South Korea Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 184 South Korea Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 185 South-East Asia Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 186 South-East Asia Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 187 South-East Asia Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 188 South-East Asia Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 189 South-East Asia Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 190 South-East Asia Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 191 South-East Asia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 192 South-East Asia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 193 Rest of Asia Pacific Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 194 Rest of Asia Pacific Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 195 Rest of Asia Pacific Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 196 Rest of Asia Pacific Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 197 Rest of Asia Pacific Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 198 Rest of Asia Pacific Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 199 Rest of Asia Pacific Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 200 Rest of Asia Pacific Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 201 Latin America Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 202 Latin America Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 203 Latin America Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 204 Latin America Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 205 Latin America Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 206 Latin America Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 207 Latin America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 208 Latin America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 209 Brazil Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 210 Brazil Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 211 Brazil Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 212 Brazil Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 213 Brazil Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 214 Brazil Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 215 Brazil Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 216 Brazil Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 217 Argentina Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 218 Argentina Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 219 Argentina Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 220 Argentina Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 221 Argentina Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 222 Argentina Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 223 Argentina Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 224 Argentina Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 225 Rest of Latin America Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 226 Rest of Latin America Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 227 Rest of Latin America Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 228 Rest of Latin America Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 229 Rest of Latin America Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 230 Rest of Latin America Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 231 Rest of Latin America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 232 Rest of Latin America Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 233 Middle East Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 234 Middle East Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 235 Middle East Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 236 Middle East Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 237 Middle East Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 238 Middle East Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 239 Middle East Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 240 Middle East Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 241 UAE Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 242 UAE Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 243 UAE Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 244 UAE Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 245 UAE Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 246 UAE Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 247 UAE Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 248 UAE Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 249 Saudi Arabia Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 250 Saudi Arabia Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 251 Saudi Arabia Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 252 Saudi Arabia Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 253 Saudi Arabia Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 254 Saudi Arabia Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 255 Saudi Arabia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 256 Saudi Arabia Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 257 Rest of Middle East Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 258 Rest of Middle East Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 259 Rest of Middle East Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 260 Rest of Middle East Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 261 Rest of Middle East Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 262 Rest of Middle East Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 263 Rest of Middle East Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 264 Rest of Middle East Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 265 Africa Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 266 Africa Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 267 Africa Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 268 Africa Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 269 Africa Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 270 Africa Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 271 Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 272 Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 273 South Africa Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 274 South Africa Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 275 South Africa Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 276 South Africa Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 277 South Africa Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 278 South Africa Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 279 South Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 280 South Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 281 Egypt Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 282 Egypt Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 283 Egypt Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 284 Egypt Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 285 Egypt Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 286 Egypt Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 287 Egypt Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 288 Egypt Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

TABLE 289 Rest of Africa Hydatid Disease Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 290 Rest of Africa Hydatid Disease Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 291 Rest of Africa Hydatid Disease Treatment Market, by Site of Infection, 2017-2022 (US$ Mn)

TABLE 292 Rest of Africa Hydatid Disease Treatment Market, by Site of Infection, 2023-2030 (US$ Mn)

TABLE 293 Rest of Africa Hydatid Disease Treatment Market, by End-User, 2017-2022 (US$ Mn)

TABLE 294 Rest of Africa Hydatid Disease Treatment Market, by End-User, 2023-2030 (US$ Mn)

TABLE 295 Rest of Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2017-2022 (US$ Mn)

TABLE 296 Rest of Africa Hydatid Disease Treatment Market, by Severity and Stage of Disease, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current size of the global hydatid disease treatment market?

The global hydatid disease treatment market was valued at USD XX million in 2022.

What is the expected growth rate of the hydatid disease treatment market between 2023 and 2030?

The hydatid disease treatment market is expected to grow at a CAGR of 5.6% between 2023 and 2030, reaching USD XX million in 2030.

Which category is leading the market share in terms of treatment type?

Medical treatment is the leading segment by treatment type, holding over 58% share in value in 2022.

Which site of infection segment governs the global demand for hydatid disease treatment?

The hepatic hydatid disease (infection in the liver) segment governs the global demand for hydatid disease treatment, holding a massive share of over 40% in 2022.

Which end-user segment will post the highest CAGR in the forecast period?

The surgical centers segment will post the highest CAGR over the projection period.

Which region is fueling the growth of the hydatid disease treatment industry?

North America is fueling the robust growth of the hydatid disease treatment industry, with over one-third of its share in 2022.

Who are the major players in the global hydatid disease treatment market?

The top players include Amneal Pharmaceuticals LLC, GSK Plc, Abbott Laboratories Inc, Merck KGaA, Janssen Global Services LLC (Johnson & Johnson Services Inc), Lupin Limited, Cadila Pharmaceuticals Limited, Zydus Group, Mankind Pharma, Ipca Laboratories Ltd, and Others.

What are the major market drivers of the hydatid disease treatment industry?

The major market drivers of the hydatid disease treatment industry include high disease prevalence in endemic regions and continuous advancements in treatment modalities.

What are the major market restraints of the hydatid disease treatment industry?

The major market restraints of the hydatid disease treatment industry include limited access to healthcare in rural areas and the potential for drug resistance and cyst recurrence.

What are the major market opportunities of the hydatid disease treatment industry?

The major market opportunities of the hydatid disease treatment industry include the adoption of telemedicine and telehealth solutions and ongoing research into novel therapies for more effective treatment options.

U.S. 503b Compounding Pharmacies Market

Published:
Report ID: 15988

UAE Minimally Invasive Biopsy Techniques Market

Published:
Report ID: 38790

Saudi Arabia Minimally Invasive Biopsy Technique Market

Published:
Report ID: 38766

Lung Cancer Therapeutics Market

Published:
Report ID: 38769

Breast Cancer Market

Published:
Report ID: 38761

Positive Patient Identification (PPID) Market

Published:
Report ID: 10622

Inflation Devices Market

Published:
Report ID: 38697

Microbiology Culture Market

Published:
Report ID: 38672

Medical Processing Seals Market

Published:
Report ID: 38667

Egypt In-Vitro Fertilization (IVF) Market

Published:
Report ID: 38526

Middle East Lab Titration Devices Market

Published:
Report ID: 38542

Tattoo Needles Market

Published:
Report ID: 10912

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN